Trial NCT03871348

View at ClinicalTrials.gov 
Org. Study IDs: TED15297
Secondary IDs: 2017-004766-94 U1111-1205-1176

Last trial update was posted on 2024-03-05

MeSH Interventions

Cemiplimab

MeSH Conditions

Neoplasm Metastasis

Other Conditions

Metastatic Neoplasm

Stopping Reasons

Sponsor terminated the study for non-safety reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID